JPH0362448B2 - - Google Patents
Info
- Publication number
- JPH0362448B2 JPH0362448B2 JP60237069A JP23706985A JPH0362448B2 JP H0362448 B2 JPH0362448 B2 JP H0362448B2 JP 60237069 A JP60237069 A JP 60237069A JP 23706985 A JP23706985 A JP 23706985A JP H0362448 B2 JPH0362448 B2 JP H0362448B2
- Authority
- JP
- Japan
- Prior art keywords
- polypropylene
- porous membrane
- membrane
- porous
- organic filler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012528 membrane Substances 0.000 claims description 103
- -1 polypropylene Polymers 0.000 claims description 56
- 239000004743 Polypropylene Substances 0.000 claims description 53
- 229920001155 polypropylene Polymers 0.000 claims description 53
- 239000010410 layer Substances 0.000 claims description 33
- 239000012766 organic filler Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000011148 porous material Substances 0.000 claims description 20
- 230000035699 permeability Effects 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000003484 crystal nucleating agent Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000012792 core layer Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 150000008282 halocarbons Chemical group 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 5
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 description 41
- 238000000926 separation method Methods 0.000 description 27
- 238000000034 method Methods 0.000 description 17
- 239000000306 component Substances 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 12
- 210000000601 blood cell Anatomy 0.000 description 11
- 238000001816 cooling Methods 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 229940057995 liquid paraffin Drugs 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000001994 activation Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 239000000110 cooling liquid Substances 0.000 description 7
- 230000004913 activation Effects 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 230000024203 complement activation Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000007711 solidification Methods 0.000 description 4
- 230000008023 solidification Effects 0.000 description 4
- AJDIZQLSFPQPEY-UHFFFAOYSA-N 1,1,2-Trichlorotrifluoroethane Chemical compound FC(F)(Cl)C(F)(Cl)Cl AJDIZQLSFPQPEY-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 229920002301 cellulose acetate Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000635 electron micrograph Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
- 241001125929 Trisopterus luscus Species 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 229950005499 carbon tetrachloride Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000011045 prefiltration Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229920001384 propylene homopolymer Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229950011008 tetrachloroethylene Drugs 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- UGCSPKPEHQEOSR-UHFFFAOYSA-N 1,1,2,2-tetrachloro-1,2-difluoroethane Chemical compound FC(Cl)(Cl)C(F)(Cl)Cl UGCSPKPEHQEOSR-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 description 1
- 229940099364 dichlorofluoromethane Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003779 heat-resistant material Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 230000009390 immune abnormality Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Filtering Materials (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60237069A JPS6297603A (ja) | 1985-10-23 | 1985-10-23 | ポリプロピレン多孔質膜およびその製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60237069A JPS6297603A (ja) | 1985-10-23 | 1985-10-23 | ポリプロピレン多孔質膜およびその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6297603A JPS6297603A (ja) | 1987-05-07 |
| JPH0362448B2 true JPH0362448B2 (en]) | 1991-09-26 |
Family
ID=17009954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60237069A Granted JPS6297603A (ja) | 1985-10-23 | 1985-10-23 | ポリプロピレン多孔質膜およびその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6297603A (en]) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR940008074B1 (ko) * | 1987-01-20 | 1994-09-01 | 데루모 가부시끼가이샤 | 폴리프로필렌 다공질막 |
| US5186835A (en) * | 1987-09-11 | 1993-02-16 | Agency Of Industrial Science And Technology | Porous hydrophilic polypropylene membrane, method for production thereof, and blood plasma separation apparatus |
| JP2501891B2 (ja) * | 1987-09-11 | 1996-05-29 | 工業技術院長 | 親水性ポリプロピレン多孔質膜および血漿分離装置 |
| CA1329559C (en) * | 1988-03-03 | 1994-05-17 | Keiji Naoi | Leukocyte separator and method of making the same |
| JP4820340B2 (ja) * | 2007-07-20 | 2011-11-24 | 中国電力株式会社 | 浚渫排水浄化システム |
-
1985
- 1985-10-23 JP JP60237069A patent/JPS6297603A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6297603A (ja) | 1987-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940008074B1 (ko) | 폴리프로필렌 다공질막 | |
| US4927576A (en) | Method for the manufacture of flat permeable membrane | |
| JPH0683724B2 (ja) | 血液成分分離用多孔質膜およびその製造方法 | |
| US4964991A (en) | Flat permeable membrane and for manufacture thereof | |
| JPH0362448B2 (en]) | ||
| JP2023135799A (ja) | ポリオレフィン微多孔膜および濾過フィルター | |
| EP0388468B1 (en) | Hydrophilic polypropylene porous membrane, process for its production, and apparatus for separating blood plasma | |
| JP7152106B2 (ja) | ポリオレフィン微多孔膜及び液体フィルター | |
| JPH03174230A (ja) | 平膜型透過性膜 | |
| JPH0555174B2 (en]) | ||
| JP2501891B2 (ja) | 親水性ポリプロピレン多孔質膜および血漿分離装置 | |
| JPS5958041A (ja) | ポリスルホン多孔膜の製造方法 | |
| JPH0563212B2 (en]) | ||
| JPH0362447B2 (en]) | ||
| JPH0474046B2 (en]) | ||
| JPH06269645A (ja) | ウィルス分離用膜及びその製造方法 | |
| JPS60172313A (ja) | エンドトキシン除去材および除去方法 | |
| JPH01228505A (ja) | 多孔質中空糸膜、その製造方法およびその中空糸膜を用いた人工肺 | |
| JPS59183761A (ja) | 血漿分離膜及びその製造方法 | |
| JPH0515492B2 (en]) |